165 related articles for article (PubMed ID: 21424400)
1. High-dose chemotherapy followed by autologous and allogeneic peripheral blood stem cell transplantation for recurrent disseminated trilateral retinoblastoma.
Tsuruta T; Aihara Y; Kanno H; Kiyotani C; Maebayashi K; Sakauchi M; Osawa M; Fujii H; Kubo O; Okada Y
Childs Nerv Syst; 2011 Jun; 27(6):1019-24. PubMed ID: 21424400
[TBL] [Abstract][Full Text] [Related]
2. Tandem high-dose chemotherapy followed by autologous stem cell transplantation: An infant with trilateral retinoblastoma.
Toret E; Ozdemir ZC; Zengin Ersoy G; Oztunali C; Bozkurt C; Kebudi R
Pediatr Transplant; 2023 Jun; 27(4):e14504. PubMed ID: 36919672
[TBL] [Abstract][Full Text] [Related]
3. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
[TBL] [Abstract][Full Text] [Related]
4. Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV; Sampor C; Laurent VE; Aschero R; Iyer S; Rossi J; Alderete D; Alonso DF; Szijan I; Chantada GL
Br J Ophthalmol; 2018 Nov; 102(11):1597-1601. PubMed ID: 30150278
[TBL] [Abstract][Full Text] [Related]
5. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
Shim BY; Lee MA; Byun JH; Roh SY; Song CW; Park JN; Lee JW; Min WS; Hong YS; Kim CC
Korean J Intern Med; 2004 Jun; 19(2):114-20. PubMed ID: 15366643
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy followed by stem cell transplantation in the management of retinoblastoma: a systematic review.
Jaradat I; Mubiden R; Salem A; Abdel-Rahman F; Al-Ahmad I; Almousa A
Hematol Oncol Stem Cell Ther; 2012; 5(2):107-17. PubMed ID: 22828375
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.
Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W
Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463
[TBL] [Abstract][Full Text] [Related]
8. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
[TBL] [Abstract][Full Text] [Related]
9. Primary pineal rhabdomyosarcoma successfully treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation: case report.
Ishi Y; Yamaguchi S; Iguchi A; Cho Y; Ohshima J; Hatanaka KC; Takakuwa E; Kobayashi H; Terasaka S; Houkin K
J Neurosurg Pediatr; 2016 Jul; 18(1):41-5. PubMed ID: 26942266
[TBL] [Abstract][Full Text] [Related]
10. Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
Hertzberg H; Kremens B; Velten I; Beck JD; Greil J
Bone Marrow Transplant; 2001 Mar; 27(6):653-5. PubMed ID: 11319597
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma.
Dunkel IJ; Chan HS; Jubran R; Chantada GL; Goldman S; Chintagumpala M; Khakoo Y; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):149-52. PubMed ID: 20486181
[TBL] [Abstract][Full Text] [Related]
12. Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.
Ueda T; Maeda T; Kusakabe S; Fujita J; Fukushima K; Yokota T; Shibayama H; Tomiyama Y; Kanakura Y
Int J Hematol; 2019 Feb; 109(2):197-205. PubMed ID: 30448938
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy for high-risk retinoblastoma: clinical course and outcome of 14 cases in the National Cancer Center, Japan.
Yasui N; Kawamoto H; Fujiwara M; Aihara Y; Ogawa C; Hosono A; Suzuki S
Bone Marrow Transplant; 2015 Feb; 50(2):221-4. PubMed ID: 25437249
[TBL] [Abstract][Full Text] [Related]
14. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report.
De Ioris MA; Fidani P; Munier FL; Serra A; Ilari I; Popovic MB; Natali G; Secco DE; Cozza R
J Pediatr Hematol Oncol; 2010 Nov; 32(8):e343-5. PubMed ID: 20881869
[TBL] [Abstract][Full Text] [Related]
16. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors.
Hawkins D; Barnett T; Bensinger W; Gooley T; Sanders J
Med Pediatr Oncol; 2000 May; 34(5):328-37. PubMed ID: 10797354
[TBL] [Abstract][Full Text] [Related]
17. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
Cesaro S; Gazzola MV; Marson P; Calore E; Caenazzo L; Destro R; De Silvestro G; Varotto S; Pillon M; Zanesco L; Messina C
Am J Hematol; 2003 Feb; 72(2):143-6. PubMed ID: 12555220
[TBL] [Abstract][Full Text] [Related]
18. Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
Saarinen UM; Sariola H; Hovi L
Am J Pediatr Hematol Oncol; 1991; 13(3):315-9. PubMed ID: 1793158
[TBL] [Abstract][Full Text] [Related]
19. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Dai S; Dimaras H; Héon E; Budning A; Doyle J; Halliday W; Drake J; Gallie BL; Chan HS
Ophthalmic Genet; 2008 Sep; 29(3):120-5. PubMed ID: 18766991
[TBL] [Abstract][Full Text] [Related]
20. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]